|
Patient Safety/ Medical Error
Citations 171-180 of 299 total displayed.
|
Past content
(since Feb 1998):
|
- Original Contributions
Adverse Reactions to Allogeneic Whole Blood Donation by 16- and 17-Year-Olds
- Anne F. Eder; Christopher D. Hillyer; Beth A. Dy; Edward P. Notari IV; Richard J. Benjamin
JAMA 2008; 299: 2279-2286.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ]
- Reviews
Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis
- Charles Natanson; Steven J. Kern; Peter Lurie; Steven M. Banks; Sidney M. Wolfe
JAMA 2008; 299: 2304-2312.
[Abstract]
[Full text]
[PDF]
[ Incomplete Financial Disclosure ]
- Commentaries
The Deregulatory Effects of Preempting Tort Litigation: FDA Regulation of Medical Devices
- Lawrence O. Gostin
JAMA 2008; 299: 2313-2316.
[Extract]
[Full text]
[PDF]
- Editorials
The Future of Clinical Trials Evaluating Blood Substitutes
- Dean A. Fergusson; Lauralyn McIntyre
JAMA 2008; 299: 2324-2326.
[Extract]
[Full text]
[PDF]
- Commentaries
The Wisdom and Justice of Not Paying for "Preventable Complications"
- Peter J. Pronovost; Christine A. Goeschel; Robert M. Wachter
JAMA 2008; 299: 2197-2199.
[Extract]
[Full text]
[PDF]
- Commentaries
Barcoded Medication Administration: A Last Line of Defense
- David W. Cescon; Edward Etchells
JAMA 2008; 299: 2200-2202.
[Extract]
[Full text]
[PDF]
- Commentaries
FDA Guidance on Off-Label Promotion and the State of the Literature From Sponsors
- Bruce M. Psaty; Wayne Ray
JAMA 2008; 299: 1949-1951.
[Extract]
[Full text]
[PDF]
- Medical News & Perspectives
FDA to Boost Its Presence in China
- Bridget M. Kuehn
JAMA 2008; 299: 1762.
[Extract]
[Full text]
[PDF]
- Original Contributions
Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial
- MEND-CABG II Investigators*
JAMA 2008; 299: 1777-1787.
[Abstract]
[Full text]
[PDF]
- Special Communications
Reporting Mortality Findings in Trials of Rofecoxib for Alzheimer Disease or Cognitive Impairment: A Case Study Based on Documents From Rofecoxib Litigation
- Bruce M. Psaty; Richard A. Kronmal
JAMA 2008; 299: 1813-1817.
[Abstract]
[Full text]
[PDF]
[ JAMA Report Video ]
|
|
